INVESTORS & MEDIA

TARRYTOWN, N.Y., Feb. 13, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

• 2015 RBC Capital Markets' Global Healthcare Conference at 8:30 a.m. Eastern Time on Tuesday, February 24, 2015              
• Cowen and Company 35^th Annual Healthcare Conference at 9:20 a.m. Eastern Time on Tuesday, March 3, 2015
• Barclays Global Healthcare Conference at 9:30 a.m. Eastern Time on Wednesday, March 11, 2015

The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron commercializes medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.

Contact Information:

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-2015-investor-conference-presentations-300035568.html

SOURCE Regeneron Pharmaceuticals, Inc.